You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

H3K27M

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

H3 K27M, Glioma Trial in Santa Monica (ONC201, ONC201 + Placebo, Placebo)

Recruiting
  • H3 K27M
  • Glioma
  • Santa Monica, California
    Providence Saint John's Cancer Institute
Nov 28, 2022

Diffuse Midline Glioma, H3 K27M-Mutant Trial in San Francisco (Cyclophosphamide, Fludarabine, Autologous Anti-H3.3K27M

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • San Francisco, California
    University of California, San Francisco
Aug 15, 2022

Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Glioma Trial (Re-irradiation)

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • +5 more
  • Re-irradiation
  • (no location specified)
Oct 16, 2023

Glioblastoma, Diffuse Midline Glioma, H3 K27M Glioma Trial in United States (ONC201)

Active, not recruiting
  • Glioblastoma
  • +5 more
  • Los Angeles, California
  • +4 more
Apr 8, 2022

Glioma Trial in Philadelphia (ONC201)

No longer available
  • Glioma
  • Philadelphia, Pennsylvania
    Oncoceutics
Mar 10, 2022

CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

Not yet recruiting
  • Central Nervous System Neoplasms
  • +6 more
  • B7-H3-CAR T cells
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Apr 18, 2023

Diffuse Midline Glioma, H3 K27M-Mutant Trial (GD2 CAR T cells)

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • GD2 CAR T cells
  • (no location specified)
Sep 15, 2022

Diffuse Midline Glioma, H3 K27M-Mutant Trial in Rochester (Hypofractionated Radiation Therapy, Quality-of-Life Assessment,

Recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • Hypofractionated Radiation Therapy
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in New York (Etoposide; Oral, 50 Mg, Focused

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • Etoposide; Oral, 50 Mg
  • Focused ultrasound with neuro-navigator-controlled sonication
  • New York, New York
    Columbia University Irving Medical Center
Feb 28, 2023

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Villejuif (Everolimus, ONC201, Radiotherapy)

Not yet recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jul 27, 2022

Glioma, H3 K27M Trial in United States (ONC201)

Available
  • Glioma
  • H3 K27M
  • Phoenix, Arizona
  • +21 more
Sep 23, 2022

Diffuse Intrinsic Pontine Glioma, Glioma, Malignant Trial in United States (ONC201)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Glioma, Malignant
  • San Francisco, California
  • +7 more
Mar 1, 2022

Newly Diagnosed H3-mutated Glioma Trial in Germany (drug, biological, other)

Recruiting
  • Newly Diagnosed H3-mutated Glioma
  • Tecentriq 1200 MG in 20 ML Injection
  • +2 more
  • Mannheim, Baden-Wuerttemberg, Germany
  • +7 more
Jan 18, 2023

Diffuse Intrinsic Pontine Glioma Trial in Beijing (Histone H3.3-K27M Neoantigen Vaccine Therapy)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Histone H3.3-K27M Neoantigen Vaccine Therapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Jul 18, 2022

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Orange, Chicago, Boston (rHSC-DIPGVax,

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • rHSC-DIPGVax
  • +2 more
  • Orange, California
  • +2 more
Nov 10, 2022

Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

Recruiting
  • Cancer
  • +18 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 12, 2022

Glioma, Glioneuronal Tumor, Choroid Plexus Tumor Trial (Observational)

Not yet recruiting
  • Glioma
  • +12 more
  • Observational
  • (no location specified)
Feb 17, 2022

High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)

Not yet recruiting
  • High Grade Glioma
  • +8 more
  • Aurora, Colorado
  • +17 more
May 2, 2023

Diffuse Intrinsic Pontine Glioma, Diffuse Pontine and Thalamic Gliomas, Diffuse Midline Glioma, H3 K27M-Mutant Trial in New York

Active, not recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +2 more
  • Panobinostat 15 MG
  • Focused Ultrasound with neuro-navigator-controlled sonication
  • New York, New York
    Columbia University Irving Medical Center / NewYork-Presbyterian
Feb 3, 2022

Glioma Trial in United States (ONC201)

Active, not recruiting
  • Glioma
  • San Francisco, California
  • +8 more
Jul 14, 2022

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    International Diffuse Intrinsic Pontine Glioma/Diffuse Midline

    Recruiting
    • Diffuse Intrinsic Pontine Glioma
    • +2 more
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Jun 18, 2021

      CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

      Recruiting
      • Central Nervous System Neoplasms
      • +22 more
      • Bethesda, Maryland
        National Institutes of Health
      Mar 1, 2022

      Brodalumab in Plaque Psoriasis to Understand Impact on Quality

      Recruiting
      • Psoriasis
      • Brodalumab
      • Matched cohort
      • Calgary, Alberta, Canada
      • +33 more
      Oct 8, 2022

      Hidradenitis Suppurativa Trial in Worldwide (Sonelokimab (M1095), Adalimumab, Placebo)

      Recruiting
      • Hidradenitis Suppurativa
      • Sonelokimab (M1095)
      • +2 more
      • Fountain Valley, California
      • +56 more
      Feb 1, 2023